Literature DB >> 28288318

Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.

Uzma Salar1, Khalid Mohammed Khan2, Jamshed Iqbal3, Syeda Abida Ejaz4, Abdul Hameed1, Mariya Al-Rashida5, Shahnaz Perveen6, Muhammad Nawaz Tahir7.   

Abstract

A library of coumarin derived sulfonyl esters (1-38) was synthesized by reacting various hydroxy coumarins with different alkyl and aryl sulfonyl chlorides. All compounds were evaluated for their potential to inhibit alkaline phosphatases (hTNAP and hIAP). Most of the compounds were found to be inhibitors of APs. Compound 20 was found to be the most active hIAP inhibitor (IC50 = 1.11 ± 0.15 μM), whereas, compound 13 was found to be the most active hTNAP inhibitor (IC50 = 0.58 ± 0.17 μM). Detailed structure activity relationship studies (SAR), and molecular docking studies were carried out to identify structural elements necessary for AP inhibition, in addition to rationalize most probable binding site interaction of the inhibitors with the AP enzymes.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alkaline phosphatase; Coumarins; Docking studies; Inhibitory activity; SAR; Sulfonates

Mesh:

Substances:

Year:  2017        PMID: 28288318     DOI: 10.1016/j.ejmech.2017.03.003

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Synthesis, in vitro [Formula: see text]-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives.

Authors:  Muhammad Ali; Khalid Mohammed Khan; Uzma Salar; Mohammed Ashraf; Muhammad Taha; Abdul Wadood; Sujhla Hamid; Muhammad Riaz; Basharat Ali; Shahbaz Shamim; Farman Ali; Shahnaz Perveen
Journal:  Mol Divers       Date:  2018-05-29       Impact factor: 2.943

2.  2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies.

Authors:  Jamshaid Ashraf; Ehsan Ullah Mughal; Reem I Alsantali; Amina Sadiq; Rabab S Jassas; Nafeesa Naeem; Zaman Ashraf; Yasir Nazir; Muhammad Naveed Zafar; Amara Mumtaz; Masoud Mirzaei; Satar Saberi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-10-29       Impact factor: 4.036

3.  Tricyclic coumarin sulphonate derivatives with alkaline phosphatase inhibitory effects: in vitro and docking studies.

Authors:  Jamshed Iqbal; Mohammed I El-Gamal; Syeda Abida Ejaz; Joanna Lecka; Jean Sévigny; Chang-Hyun Oh
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.